Respiratory Pathology
Respiratory pathology is the branch of systemic pathology concerned with diseases of the airways, lung parenchyma, pulmonary vasculature, and pleura. It links the structural changes seen in tissue and on imaging to the functional consequences of impaired gas exchange, organising a large group of disorders that are among the leading causes of illness and death worldwide.
Definition
Respiratory pathology is the study of the causes, mechanisms, structural changes, and functional effects of diseases affecting the respiratory tract, from the conducting airways and alveoli to the pulmonary circulation and pleural surfaces.
Scope
This area orients the reader to the major categories of lung disease as pathological processes: infections of the lung (pneumonia), chronic airflow obstruction (chronic obstructive pulmonary disease), vascular disease (pulmonary embolism), malignancy (lung cancer), and diffuse parenchymal scarring (interstitial lung disease). It frames how each process disrupts the alveolar-capillary unit; it is reference-educational and does not provide clinical management instructions.
Sub-topics
Core questions
- Which compartment of the lung is primarily injured: airway, alveolus, interstitium, vasculature, or pleura?
- Is the process infectious, neoplastic, obstructive, restrictive, or vascular in nature?
- How does the structural lesion translate into impaired gas exchange or airflow?
- What patterns distinguish acute, reversible injury from chronic, fibrotic, or irreversible change?
Key concepts
- Alveolar-capillary (gas-exchange) unit
- Obstructive versus restrictive ventilatory patterns
- Ventilation-perfusion (V/Q) matching and mismatch
- Acute lung injury and diffuse alveolar damage
- Tissue remodelling and fibrosis
- Airway inflammation and mucus hypersecretion
- Pulmonary circulation and pulmonary hypertension
Mechanisms
Respiratory diseases converge on a small set of injury patterns. Infections trigger inflammatory filling of alveoli; chronic irritant exposure (notably tobacco smoke) drives airway inflammation, mucus hypersecretion, and alveolar destruction; vascular occlusion interrupts perfusion; carcinogen-driven mutation produces malignancy; and chronic or repeated injury to the interstitium produces fibrosis. Across these categories the final common consequence is disruption of the alveolar-capillary unit, leading to hypoxaemia, altered carbon dioxide clearance, and changes in lung compliance or airflow.
Clinical relevance
The categories grouped here account for a large share of global respiratory morbidity and mortality, and recognising the dominant pathological pattern underlies how clinicians and pathologists interpret imaging, function tests, and tissue. This area describes disease processes for educational reference and is not a source of diagnostic or treatment recommendations.
Epidemiology
Respiratory conditions are collectively a leading cause of death and disability worldwide; the Global Burden of Disease analyses rank lower respiratory infections, chronic obstructive pulmonary disease, and lung cancer among the foremost causes of death, while pulmonary embolism and interstitial lung diseases add substantial vascular and fibrotic burden.
History
Modern respiratory pathology grew from the correlation of clinical signs with post-mortem and microscopic findings in the nineteenth and twentieth centuries, and was reshaped by chest radiography, computed tomography, pulmonary function testing, and molecular profiling, which together allow pathological processes to be characterised in living patients.
Related topics
Seminal works
- kumar-robbins-2020
- wang-2016-gbd
Frequently asked questions
- What does respiratory pathology cover?
- It covers diseases of the airways, lung parenchyma, pulmonary blood vessels, and pleura, grouping them by the underlying process: infection, obstruction, vascular disease, malignancy, and fibrosis.
- What is the difference between obstructive and restrictive lung disease?
- Obstructive disease limits airflow out of the lungs (as in chronic obstructive pulmonary disease), whereas restrictive disease limits lung expansion and volume (as in many interstitial lung diseases); the distinction is a foundational organising concept in respiratory pathology.